In conclusion, this study demonstrated that 4AAQB inhibited both cancer growth and angiogenesis in vitro by inhibiting the activation of the VEGFR2, PI3K/Akt, mTOR, and ERK pathways. The gene discussed is AKT1; the disease is cancer.